Page last updated: 2024-10-30

meclofenamic acid and Hypertension, Malignant

meclofenamic acid has been researched along with Hypertension, Malignant in 1 studies

Meclofenamic Acid: A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.
meclofenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,6-dichloro-3-methylphenyl group. A non-steroidal anti-inflammatory drug, it is used as the sodium salt for the treatment of dysmenorrhoea (painful periods), osteoarthritis and rheumatoid arthritis.

Hypertension, Malignant: A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Opay, AL1
Mouton, CR1
Mullins, JJ1
Mitchell, KD1

Other Studies

1 other study available for meclofenamic acid and Hypertension, Malignant

ArticleYear
Cyclooxygenase-2 inhibition normalizes arterial blood pressure in CYP1A1-REN2 transgenic rats with inducible ANG II-dependent malignant hypertension.
    American journal of physiology. Renal physiology, 2006, Volume: 291, Issue:3

    Topics: Angiotensin II; Animals; Animals, Genetically Modified; Blood Pressure; Cyclooxygenase 1; Cyclooxyge

2006